Hearing Screening for Childhood Hearing Loss
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to identify the best method for screening preschoolers for hearing loss to prevent speech and language delays. It compares two methods: a single-stage test using otoacoustic emissions (OAE), which checks for sounds produced by the inner ear, and a two-stage test combining pure-tone audiometry (PTA) and OAE. The goal is to determine if the simpler OAE test alone is as effective as the combined approach in detecting hearing issues. Children attending community-based preschools who do not have known hearing problems or use hearing aids may be eligible to participate. This study could lead to improved early detection and intervention for children who are deaf or hard-of-hearing, enhancing their communication skills. As an unphased trial, this study provides a unique opportunity to contribute to research that could advance early hearing loss detection in children.
Do I need to stop my child's current medications for the trial?
The trial information does not specify whether children need to stop taking their current medications.
What prior data suggests that these hearing screening methods are safe for preschool children?
Research shows that otoacoustic emissions (OAE) testing and pure tone audiometry (PTA) are safe and well-tolerated methods for checking children's hearing.
OAE testing examines how the inner ear responds to sound. Studies have shown it's quick and causes no discomfort, making it ideal for young children. Experts recommend it as a reliable way to detect hearing problems early, allowing for prompt intervention.
Pure tone audiometry, in contrast, is considered the gold standard for hearing tests. It assesses how well a child can hear different sounds and is effective for children around five years old and up.
Both methods are supported by research and are commonly used in children's hearing tests. They are designed to be safe and comfortable, with no reports of serious side effects, making them trusted tools for early detection of hearing issues.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative methods for screening childhood hearing loss. The Single-Stage OAE (SS-O) approach is unique because it uses otoacoustic emissions to quickly detect hearing issues without needing a second test if the child passes. On the other hand, the Two-stage PTA+OAE method combines pure tone audiometry with otoacoustic emissions testing, offering a comprehensive assessment. These techniques could streamline the screening process, potentially making it faster and more efficient than traditional methods, which often rely on more extensive and time-consuming evaluations.
What evidence suggests that this trial's hearing screening methods could be effective for identifying hearing loss in preschoolers?
Research shows that checking for hearing issues using otoacoustic emissions (OAE) effectively identifies hearing loss in preschool children. Studies have found that OAE tests successfully detect hearing problems in almost all children tested, making it a dependable method. In this trial, one group of participants will undergo a single-stage OAE hearing screening. Pure-tone audiometry (PTA), often used with OAE, assesses how a child responds to different sounds. In this trial, another group will undergo a two-stage screening using both PTA and OAE. This approach is considered the best way to catch hearing issues early, ensuring quick identification of potential hearing problems, which can help prevent delays in speech and language development.46789
Who Is on the Research Team?
Dylan K Chan, MD, PhD
Principal Investigator
The University of California - San Francisco
Are You a Good Fit for This Trial?
This trial is for preschool children aged between 2 and 6 years who are enrolled in community-based preschool programs. It's not for kids whose parents don't consent, those already screened in this study, absent on screening day, using hearing aids, or known to have permanent hearing loss.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Data Collection
Children undergo both PTA and OAE screening to collect data for group allocation
Diagnostic Testing
Further testing for children who show potential hearing issues based on screening results
Follow-up
Participants are monitored for hearing outcomes and effectiveness of screening methods
What Are the Treatments Tested in This Trial?
Interventions
- Otoacoustic Emissions Testing
- Pure Tone Audiometry
Otoacoustic Emissions Testing is already approved in United States, European Union, Canada for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator